Carl Erik Mathias Uhlén

Carl Erik Mathias Uhlén

Directeur/Membre du Conseil chez INTERVACC AB
72 ans
Health Technology
Commercial Services
Finance

Profil

Carl Erik Mathias Uhlén was the founder of AbClon, Inc. (founded in 2010), Biotage AB (founded in 1997) where the title held was Director, Affibody Medical AB (founded in 1998) where the title held was Deputy Chairman, Atlas Antibodies AB (founded in 2006) where the title held was Director, and Affibody AB (founded in 1998) where the title held was Deputy Chairman.
Current jobs include Chairman at Antibodypedia AB, Antibodies Incentive AB, and Scandibio Therapeutics AB; Director at Human Proteome Organization, Woodheads AB, Atlas Intresenter AB, Science for Life Laboratory, Stockholm Science City Foundation, Mu Bioteknik AB, NorthX Biologics Matfors AB (since 2022), and several academic and scientific organizations including the Royal Swedish Academy of Sciences (Member since 2010), Technical University of Denmark (Professor), Royal Institute of Technology (Professor), National Academy of Engineering (Member), and Royal Swedish Academy of Engineering Sciences (Member since 2010); Independent Director at Intervacc AB (since 2024); and Advisor at HealthCap AB. Former jobs include Chairman at Magnetic Biosolutions AB; Independent Director at Novozymes A (2007–2022), Bure Equity AB, and Alligator Bioscience AB; Director at NORDA ASA (2007), Skanditek Industriförvaltning AB, Stiftelsen för Strategisk Forskning, SweTree Technologies AB, KTH Holding AB, Swetree Genomics AB, Atlas Therapeutics AB.

Postes actifs de Carl Erik Mathias Uhlén

SociétésPosteDébut
INTERVACC AB Directeur/Membre du Conseil 01/01/2024
Fondateur 01/01/1998
Human Proteome Organization
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Consultant / Advisor -
Directeur/Membre du Conseil 14/06/2022
Président -
Directeur/Membre du Conseil -
Antibodies Incentive AB
Président -
░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -

Anciens postes connus de Carl Erik Mathias Uhlén

SociétésPosteFin
░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
Voir l'expérience en détail de Carl Erik Mathias Uhlén

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

76

Relations au 1er degré

33

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées33

Process Industries

Commercial Services

Health Technology

Finance

Finance

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Miscellaneous

Consumer Services

Health Technology

Commercial Services

Commercial Services

Human Proteome Organization

Non-Energy Minerals

Finance

Swetree Genomics AB

Health Technology

Health Technology

Atlas Intresenter AB

Antibodypedia AB

Health Technology

Commercial Services

Commercial Services

Miscellaneous

Antibodies Incentive AB

Health Technology

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Carl Erik Mathias Uhlén
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT